Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971
John.lezcano@informa.com
pharmaintelligence.informa.com

Syncona CEO On Why Its 10th Start-Up Focuses On T-Regulatory Cell Therapies

Tue, 05/21/2019 - 8:47am

UK investment group Syncona Ltd has financed its tenth start-up, Quell Therapeutics, with the aim of developing engineered T regulatory...

      Related Stories 

Deal Watch: Ireland's Amryt Acquires Aegerion

Tue, 05/21/2019 - 7:24am

European firms Amryt and Evotec have signed agreements to acquire two companies based across the Atlantic – Aegerion and Just...

      Related Stories 

Product Delays Dull Dr Reddy’s Despite Upbeat Management

Mon, 05/20/2019 - 11:32pm

Dr Reddy’s had a generally positive Q4 but a slow ramp in some products in the US and potential delays...

      Related Stories 

Penalty For Daiichi As It Falls Short In Japan Flu Vaccine Project

Mon, 05/20/2019 - 10:08pm

Japanese firm fails to meet production capacity target under Japan national flu vaccine supply plan, triggering a financial penalty and...

      Related Stories 

VIDEO: What We Learned From Q1 Pharma Earnings Season

Mon, 05/20/2019 - 4:41am

With US drug pricing pressures and generic and biosimilar competition weighing on big pharma, new launches and brisk business in...

      Related Stories 

CHART/TABLE: Pipeline Watch: Phase III Readouts For Ivosidenib, Abrocitinib, Spartalizumab

Mon, 05/20/2019 - 1:34am

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...

      Related Stories 

Basilea-Pfizer’s Cresemba Heads For Indian Debut

Sun, 05/19/2019 - 5:57pm

Basilea’s Cresemba appears on course to a debut in India and partner Pfizer expects the novel antifungal to bolster its...

      Related Stories 

Celltrion To Invest $33.6bn As It Lays Out Long-Term Ambitions

Sun, 05/19/2019 - 5:37pm

Celltrion unveils massive long-term investment plan to secure leadership in the global biopharma market, set up international sales distribution networks...

      Related Stories 

Merck And The 'Strange Business' Of Antibiotics

Fri, 05/17/2019 - 2:21pm

Antibacterials have been part of Merck's mission for decades, despite the market challenges, and it's expecting two new approvals this...

      Related Stories 

Deal Watch: Parvus Signs Second Big Pharma Alliance, With Genentech

Fri, 05/17/2019 - 12:29pm

Two years after its first big Navacim-based tie-up with Novartis, Parvus could earn beyond $800m in autoimmune R&D pact with...

      Related Stories 

Five Companies To Watch This ASCO

Fri, 05/17/2019 - 10:25am

MacroGenics, Amgen, Celgene, Forty Seven and Iovance are all set to enjoy a good ASCO meeting with promising data for key products revealed in...

      Related Stories 

£80m To Tackle Snakebite Is A Wellcome Boost

Fri, 05/17/2019 - 7:11am

Two major initiatives have been announced which hope to revolutionize the treatment of snakebites, which claims the lives of up...

      Related Stories 

Pharming Explores Further Uses For Ruconest

Fri, 05/17/2019 - 3:08am

Pre-eclampsia and nephropathy associated with the use of contrast media in cardiac patients are two new potential uses for Pharming’s...

      Related Stories 

BioGenetics Seeks To Boost Pharma Business Via Kyung Nam Acquisition

Thu, 05/16/2019 - 8:51pm

South Korean medical product manufacturer BioGenetics, which has recently diversified into the biopharma business and entered alliances for novel anticancer...

      Related Stories 

Pages